[Mechanism of action of male hormones. (Pathologic and therapeutic implications)].
D000726:Androgen Antagonists; D013734:Androgen-Insensitivity Syndrome / Q000378:metabolism; D000728:Androgens; D000818:Animals; D001665:Binding Sites; D012734:Disorders of Sex Development / Q000188:drug therapy; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006628:Hirsutism / Q000378:metabolism; D006801:Humans; D006983:Hypertrichosis / Q000188:drug therapy; D008297:Male; D010088:Oxidoreductases / Q000378:metabolism; D011467:Prostate / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000188:drug therapy; D011485:Protein Binding; D051381:Rats; D012627:Sebaceous Glands / Q000378:metabolism; D012867:Skin / Q000378:metabolism; D013739:Testosterone / Q000378:metabolism
D000726:Androgen Antagonists; D000728:Androgens; D004967:Estrogens; D013739:Testosterone; D010088:Oxidoreductases
Mécanisme d'action des hormones mâles. (Implications pathologiques et thérapeutiques.